Cosnova’s next act: From drugstore makeup dominance to a bold push into affordable, ingredient-led skincare

Key Highlights
Introduction
From lipsticks and limited editions to a new category
Why Niche Beauty Lab fits Cosnova’s playbook
The accessible, ingredient-led skincare wave and its leaders
How Cosnova plans to scale skincare: channels, infrastructure and product playbooks
Financial and strategic implications
Where Cosnova’s makeup strengths give it an edge in skincare
International expansion: sequencing markets and partners
Product strategy: bridging makeup with skin-first formulations
Integration risks and operational challenges
Competitive response and market dynamics
Why family ownership matters for strategy and pricing
Real-world analogues and lessons from other roll-ups
What success will look like — and how to measure it
Short-term roadmap and likely next steps
Challenges to watch from a stakeholder perspective
The broader implications for the beauty industry
What to expect from product innovation and marketing
FAQ

Key Highlights

Cosnova, parent of Essence and Catrice, has acquired Spanish DTC skincare house Niche Beauty Lab to expand into skincare and reduce dependence on color cosmetics; Niche generated $60 million in sales last year and will operate from its Canet de Mar HQ as Cosnova’s skincare hub.
The move targets the growing market for affordable, ingredient-driven skincare — a segment proven scalable by brands like The Ordinary — while leveraging Cosnova’s retail relationships (Walmart, CVS, Ulta, Target, Primark, Boots) and logistics investments to accelerate omnichannel expansion.

Introduction

Cosnova built a rare combination: mass-market price points paired with trend-forward, social-media-ready products. Essence and Catrice grew from drugstore stalwarts into global players by translating rapid trend cycles into accessible product franchises. That success — and the vulnerability that came with concentration in color cosmetics — prompted a strategic shift. Cosnova’s acquisition of Niche Beauty Lab positions the company to translate its formula-for-success from color into skincare, marrying ingredient credibility with mass reach. The deal offers a test of whether the value-led, science-forward skincare model can be amplified by a family-owned business that prizes long-term brand equity and tight retail execution.

From lipsticks and limited editions to a new category

Cosnova’s ascent in makeup has several visible markers: Essence became Europe’s bestselling makeup brand, the Juicy Bomb lip franchise has sold tens of millions of units, and limited-edition collaborations routinely move quickly through drugstore shelves. Those wins are the product of a repeatable engine: identify a trend, design an affordable, on-brand product, and distribute broadly across drugstores, big-box retailers and online. The engine, however, rests on color cosmetics. When a company’s top-line depends heavily on two brands, leadership faces a strategic choice: deepen the same category, or diversify.

Cosnova’s leadership chose diversification. The Niche Beauty Lab acquisition addresses three core needs: growth, diversification and capability building. Skincare already accounts for a fraction of Cosnova’s revenue — roughly 5% concentrated in Europe. The ambition is to significantly raise that share, allowing Cosnova to avoid the “standing on one foot” risk associated with category concentration. Bringing Niche into the fold gives Cosnova immediate entry to ingredient-led skincare without starting from scratch.

Why Niche Beauty Lab fits Cosnova’s playbook

Niche Beauty Lab operates three skincare brands—Acnemy, Transparent Lab and Theramid—united by a science-backed, ingredient-first approach and an accessible price stance. The brand’s DTC strength signals a direct relationship with consumers who care about ingredient lists and measurable results. Those attributes align with Cosnova’s historical strengths: translating consumer signals into mass-market hits and managing high-speed product rollouts.

Key reasons the acquisition fits:

Ready-made credibility: Niche’s formulations and positioning provide Cosnova with immediate know-how in ingredient claims, clinical positioning and product development for skincare.
DTC foundation: Niche’s direct-to-consumer profile allows Cosnova to learn from owned-data marketing — what ingredients resonate, which claims convert and how repeat purchase behaves.
Retail expansion potential: Niche had only recently begun moving into brick-and-mortar. Cosnova’s established relationships with retailers in Europe and the U.S. create a runway to scale those in-store placements quickly.
Operational and cultural continuity: Cosnova is retaining the Niche brand and its roughly 45 employees, and converting the Catalan HQ into a skincare innovation hub. That preserves institutional knowledge while integrating new capability.

The transaction also reflects a conservative growth posture. Cosnova spent two to three years searching for a partner and chose a single acquisition while signaling caution around further M&A for the next two years. That restraint reflects awareness of integration complexities and the appetite to get the first integration right.

The accessible, ingredient-led skincare wave and its leaders

Niche sits in a cohort of brands that marry clinical framing with accessible pricing. The category has shown consumers will pay attention to ingredients and clinical language when price is reasonable. Market leaders illustrate the potential.

The Ordinary: Built on clinical actives presented transparently and affordably, the brand demonstrated that simplicity and education can drive scale. Its growth has compelled legacy companies to take notice and incorporate similar offerings into their portfolios.
The Inkey List: Focused on single-ingredient solutions and plainspoken communication, the brand carved a niche with consumers who shop ingredient-first but wallet-conscious.
Minimalist: An Indian-born brand emphasizing minimalist formulations and clinical claims, it attracted major multinational interest and distribution partnerships because of its scalable model.

Estée Lauder has explicitly called out The Ordinary as a “scaling” brand and noted it contributed to skincare sales growth; net sales for such brands have moved into nine-figure territory in recent years. Cosnova’s bet rests on the hypothesis that accessible, ingredient-led skincare is not a fad but a durable segment that can be expanded via omnichannel retail muscle and product franchise management.

How Cosnova plans to scale skincare: channels, infrastructure and product playbooks

Cosnova’s distribution muscle is an advantage. The company has demonstrated capacity to move fast across retail channels, from traditional drugstores to mass and specialty chains. The playbook for scaling Niche and its brands will lean on three levers.

Omnichannel expansion
- Retail partnerships: Cosnova has established relationships across the U.S. and Europe. In the U.S., Essence is expanding to roughly 500 Walmart doors, complementing existing footprints at CVS, Ulta, Target and Amazon. In the U.K., Essence and Catrice are available through Primark and Boots.
- Brick-and-mortar push: Niche’s recent move into physical retail suggests room to scale offline. Cosnova’s experience in merchandising and in-store visibility will be leveraged to accelerate trial and conversion.
- DTC and marketplace balance: Maintaining Niche’s direct-to-consumer channel preserves customer data and loyalty programs, while marketplace and retailer partnerships deliver scale and discovery.
Logistics and fulfillment investments
- Centralized warehousing: A fully automated central warehouse scheduled to open in 2027 signals preparation for higher volumes and faster replenishment across markets.
- Regional hubs: The Dubai logistics hub will support Middle East and North African distribution, reducing lead times and strengthening regional execution.
Product architecture and franchise development
- Replicating makeup’s franchise success: Cosnova scaled makeup through product franchises (e.g., Juicy Bomb). The company sees similar opportunities in face and lip categories for ingredient-focused skincare and hybrid make-up-meets-skin products.
- Primer and face products expansion: Essence and Catrice have been emphasizing primers and face-focused SKUs — primers with hydrating and blurring properties that bridge skincare and makeup. This product-first approach aligns with consumer demand for multipurpose, skin-beneficial cosmetics.
- Limited editions and collaborations: The marketing cadence that drove fast sell-outs for limited editions and collaborations in makeup — from seasonal themes to co-branded drops — can be adapted to skincare launches and special collections to drive urgency.

These levers presuppose tight cross-functional coordination: R&D must translate clinical insights into scalable formulas; supply chain must meet retailer SLAs; marketing must educate shoppers while preserving value positioning.

Financial and strategic implications

Cosnova reported sales of approximately $1.08 billion for 2025, up 4% year-over-year, with leadership projecting “very good single-digit” growth for 2026. Skincare currently contributes a small share — around 5% — but Cosnova leadership believes that share can at least double as the company integrates Niche and expands distribution.

Several strategic outcomes flow from the acquisition:

Revenue diversification: Reducing reliance on color cosmetics will stabilize revenue against category cycles. Makeup trends can swing quickly; skincare is generally more resilient and less seasonal.
Margin dynamics: Skincare product economics can differ from makeup. Actives, clinical testing and claims compliance may increase COGS and R&D spend. Cosnova’s private ownership allows it to prioritize long-term brand equity, accepting margin trade-offs in service of strategic positioning.
Channel economics: DTC tends to carry higher gross margins but requires marketing investment for sustained acquisition. Brick-and-mortar affords trial velocity and mass reach but demands trade promotions and retailer margins. Cosnova’s mix will impact near-term profitability.

Cosnova is deliberate about integration. The company does not plan to pursue another acquisition in the immediate term, preferring to internalize the cultural and operational fit of Niche before further deals.

Where Cosnova’s makeup strengths give it an edge in skincare

Three distinct capabilities from Cosnova’s makeup playbook should translate well into skincare expansion.

Rapid trend-to-shelf execution: Cosnova has proven it can take a trend and translate it into an accessible product quickly. In skincare, speed to market matters for leveraging ingredient interest and responding to competitive moves.
Franchise management: The Juicy Bomb example shows the power of product franchises to sustain revenue through iterations and limited editions. Translating that approach to targeted skincare lines — such as a hero serum line or a clarifying collection — could deliver repeatability.
Price-value positioning: Cosnova’s consistent low-price stance has built trust among cost-conscious consumers. Applying that posture to clinical or ingredient-forward skincare can widen reach to consumers who otherwise view actives as expensive.

Cosnova’s approach to pricing in the U.S. illustrates the strategic trade-off. Management committed to holding prices steady domestically to signal value during consumer belt-tightening. Their family-owned status supports patient investment in brand equity rather than maximizing short-term margins.

International expansion: sequencing markets and partners

Cosnova is expanding into geographies that present scale and cultural fit. The company has taken a stepped approach to internationalization, pairing strategic retail partners with market-specific subsidiaries or partnerships.

United States: The U.S. is a priority retail market with both mass and specialty opportunities. Essence’s rollout into 500 Walmart doors complements presence at CVS, Ulta, Target and Amazon. The challenge will be carving shelf space in a crowded market while using exclusives (e.g., Ulta concealer launches) to build momentum.
India: Entering India via a partnership with Reliance Industries gives Cosnova access to one of the fastest-growing beauty markets. Success there depends on product-market fit and price sensitivity; Cosnova’s value positioning should help, but local marketing and distribution nuances will dictate adoption speed.
United Kingdom: Primark and Boots provide different but complementary channels — Primark for mass reach and in-store visibility, Boots for established beauty shoppers. Establishing a local subsidiary underscores Cosnova’s commitment to nuanced market execution.
Middle East and North Africa (MENA): The Dubai logistics hub demonstrates planning for regional supply efficiency. The MENA region is attractive for skincare due to varied climates and high consumer spending on beauty in certain markets.

Geographic expansion will require tailored strategies. Skin concerns, regulatory regimes and distribution norms vary by market. Cosnova’s experience with earlier expansions should reduce execution risk, but skincare’s regulatory and claims environment adds a layer of complexity.

Product strategy: bridging makeup with skin-first formulations

A defining consumer trend is the blurring of skincare and makeup. Consumers want products that support skin health while delivering aesthetic results. Cosnova’s recent primer launches — from hydrating Jelly Grip to Extreme Blur Mattifying Primer — demonstrate a deliberate move into hybrid SKUs that satisfy both sensorial and skin-focused demands.

Potential product strategy pillars:

Hero actives at value price: Center products around proven actives (e.g., hyaluronic acid, niacinamide, retinoid derivatives) in formulations that are accessible and educational.
Hybrid “makeup-meets-skin” SKUs: Build primers, tinted moisturizers and concealers with skin-benefit claims to cross-sell to Essence and Catrice users.
Franchises and formats: Create recognizable franchises (e.g., a “Clear Series” for acne-prone skin) that allow SKU proliferation while simplifying marketing.
Limited drops for discovery: Use limited editions and collaborations to drive trial and social conversation, a tactic that moved fast-selling makeup SKUs.

These choices reflect not only product development but also marketing discipline. Ingredient communication must be transparent and backed by evidence; claims must withstand retailer and regulatory scrutiny; storytelling should meet consumers where they research and shop.

Integration risks and operational challenges

Acquiring a DTC skincare house addresses capability gaps but introduces integration risks. Potential challenges include:

Cultural integration: DTC companies often have different decision-making speed, brand tone and data-first approaches compared with legacy retail operators. Preserving Niche’s innovation culture while enabling Cosnova’s scale will require deliberate change management.
Regulatory compliance and claims substantiation: Skincare claims, especially around actives and medical positioning, trigger higher standards for testing and documentation. Scaling into global retail means managing regulatory oversight across jurisdictions.
Supply chain complexity: Ingredient sourcing for actives is more complex than pigments and color cosmetics. Demand spikes, raw material shortages and quality control are real threats.
Channel conflict: Maintaining DTC while expanding into retail must be handled carefully to avoid channel cannibalization and discounting that erodes brand equity.
Pricing and margins: Ingredient-driven formulations can increase COGS. If the market perceives premium claims, retailers may expect higher price points, challenging Cosnova’s value stance.

Cosnova’s plan to keep Niche’s brand and team intact reduces some risk. The headquarters in Canet de Mar will function as an innovation center, preserving R&D capabilities and signaling a commitment to the acquired company’s identity.

Competitive response and market dynamics

Established multinationals and nimble indie brands are all contending for consumers who demand both efficacy and affordability. The competitive landscape offers both threats and opportunities.

Incumbent multinationals: L’Oréal, Procter & Gamble and Coty have scale, distribution and R&D resources. Their responses may include accelerating in-house affordable active brands or pursuing acquisitions.
Scaling indie brands: Brands like The Ordinary proved that clear ingredient communication and clinical positioning scale rapidly. Their retail rollouts into mass and prestige channels show the opportunity for brands that start DTC.
Private labels and retailers: Retailers increasingly develop private-label skincare that offers competitively priced alternatives. Cosnova’s deep retail relationships both help and complicate the go-to-market, since retailers can emulate successful SKUs.
Consumer sophistication: Shoppers are better educated about actives and expect transparency. Marketing must move beyond buzzwords to verifiable claims and educational content.

Cosnova’s differentiation rests on three points: price accessibility, proven retail execution and a portfolio approach that mixes DTC credibility with mass-market availability. Execution speed and clarity around clinical substantiation will determine whether the company captures share from both indies and incumbents.

Why family ownership matters for strategy and pricing

Cosnova frames its private, family ownership as a strategic advantage. Without the quarter-to-quarter pressure of public markets, the company can prioritize long-term brand equity and stable pricing. In a price-sensitive segment, that translates into a commitment to hold prices steady for U.S. consumers — a move aimed at winning loyalty among cost-conscious buyers.

Family ownership also influences integration decisions: a measured M&A cadence, emphasis on cultural fit and investments in infrastructure rather than short-term margin maximization. That posture matters when acquiring a DTC brand where community, transparency and authenticity underpin consumer trust. Cosnova’s public commitment to preserving Niche’s brand and staffing at the head office in Spain illustrates that approach.

Real-world analogues and lessons from other roll-ups

Several recent moves in beauty illuminate risks and opportunities for Cosnova.

Multi-brand scaling: Estée Lauder’s development of scaling brands underscores the value of integrating niche brands into larger commercial platforms. However, retaining the acquired brand’s identity while achieving operational synergies is critical. Over-integration risks alienating core customers.
Local-to-global transitions: Many indie brands that scale quickly find that international expansion requires product reformulation for regulatory compliance and careful brand communication to maintain authenticity.
Retail-first versus DTC-first: Brands that succeed at both channels often maintain differentiated assortments and pricing. For example, some brands keep hero, higher-price items DTC while offering targeted, consumer-friendly SKUs to mass retail to preserve prestige and margin.

Cosnova’s path mirrors these lessons: protect the acquired brand’s identity, invest in infrastructure to handle scale, and calibrate assortment across channels to preserve brand value.

What success will look like — and how to measure it

Short-term metrics:

Retail distribution gains: measurable growth in the number of brick-and-mortar doors and online retail partnerships carrying Niche brands.
DTC retention rates: customer acquisition cost, repeat purchase rate and lifetime value trends following integration.
SKU sell-through: velocity of hero SKUs and performance of limited editions.

Medium-term metrics:

Revenue contribution: increase in skincare share of total revenue from roughly 5% toward a materially larger slice.
Margin stability: ability to maintain Cosnova’s price-value stance while protecting gross margin through scale and supply efficiencies.
Brand perception: consumer sentiment tracking around authenticity, ingredient trust and value.

Long-term metrics:

Market share in accessible skincare: measurable position relative to established mass and indie competitors.
International footprint: successful market entries in the U.S., India and U.K. with logistics and regional supply chains operating smoothly.
Portfolio resilience: reduced volatility in total sales as skincare stabilizes revenue across category cycles.

Success will be the convergence of category diversification, sustained value positioning and a capacity to innovate without diluting brand trust.

Short-term roadmap and likely next steps

Cosnova has indicated several clear near-term priorities:

Integrate Niche operationally while preserving brand identity and the Canet de Mar innovation hub.
Expand Niche’s retail presence outside Spain by leveraging Cosnova’s European retail relationships.
Use the company’s upcoming automated warehouse (2027) and the Dubai hub to reduce time-to-market and improve supply chain responsiveness.
Continue deliberate M&A restraint to focus on operational integration.

Execution speed will matter. The skincare market is dynamic; consumers may adopt new actives quickly and competitors will seek to replicate successful formulas. Cosnova’s advantage lies in combining speed with distribution breadth — if integration is fast and friction-free, the company can iterate product offers and scale rapidly.

Challenges to watch from a stakeholder perspective

Investors, retailers and consumers will monitor a number of signals:

Quality and authenticity of ingredient claims: shoppers and regulators will scrutinize clinical claims. Missteps could trigger reputational or legal costs.
Price-position coherence across channels: too steep a discounting strategy in retails could cannibalize DTC and confuse brand positioning.
Supply chain resilience: actives supply constraints or product quality issues could undercut launches and retail relationships.
Cultural fit and talent retention: preserving talent at Niche and keeping innovation momentum intact is essential to sustaining product pipeline quality.

Cosnova’s decision to keep the Niche team and HQ intact mitigates some risks to talent and culture. The company’s family ownership and focus on long-term brand equity lower the pressure for rapid, margin-driven cost cuts that could harm product quality.

The broader implications for the beauty industry

Cosnova’s move illustrates a broader industry thesis: consumers are willing to pay attention to ingredient-driven skincare when price and communication are right. For larger beauty groups, the imperative is twofold: master digital-native brand building and scale those brands into global retail without eroding authenticity.

For retailers, the proliferation of affordable actives pressures assortment decisions. Drugstores and mass retailers must balance stocking prestige-mass hybrid brands with private labels and emerging indie brands to meet diverse shopper needs.

For founders and indie brands, Cosnova’s approach provides a blueprint: build DTC credibility through ingredient transparency, demonstrate repeatable unit economics, and maintain cultural distinctiveness to command better terms in acquisition conversations.

What to expect from product innovation and marketing

Product innovation will likely lean into:

Transparent formulations with clear callouts to actives.
Hybrid products that blur the makeup-skincare line: primers with measurable skin benefits, tinted serums, and concealers formulated for skin conditioning.
Multi-format ranges that allow consumers to trade up: DTC hero SKUs complemented by mass-market variants for retail.

Marketing will prioritize:

Education and plain-speaking ingredient narratives to build trust, particularly as consumers cross from makeup to actives.
Social-first moments and limited editions to drive discovery and urgency.
Retail-exclusive launches tying into mass distribution channels to build trial.

The simplest route to scale lies in marrying credible product science with mass distribution rituals Cosnova already knows how to execute: high-visibility shelf placement, coherent merchandising, and frequent product refreshes.

FAQ

Q: What exactly did Cosnova acquire? A: Cosnova acquired Niche Beauty Lab, a Spanish direct-to-consumer skincare company that houses three core brands — Acnemy, Transparent Lab and Theramid. Cosnova is preserving the brand and approximately 45 employees and converting the Canet de Mar headquarters into a skincare innovation hub.

Q: How large is Niche Beauty Lab? A: Niche Beauty Lab generated about $60 million in sales last year, according to the companies’ disclosures in the acquisition announcement.

Q: Why did Cosnova choose acquisition over building skincare internally? A: Acquiring Niche provides immediate ingredient-led credibility, a DTC customer base, and R&D capabilities. Building a comparable capability internally would require time and investment; acquisition accelerates market entry and reduces initial development risk while allowing Cosnova to leverage existing retail relationships.

Q: Will Cosnova change Niche’s branding or product formulas? A: Cosnova has stated it will preserve the Niche brand and its staff. The Canet de Mar HQ will become a skincare hub, indicating continuity in product development. Any future reformulations or portfolio changes will need to balance brand integrity with scale efficiencies.

Q: How will this affect Essence and Catrice? A: The acquisition allows Essence and Catrice to expand face-focused product lines and tap into skin-benefit positioning. These makeup brands have already been growing primers and other hybrid products. Cross-promotion and shared product franchises could become more prominent.

Q: What markets will Cosnova target for expansion? A: Cosnova is strengthening its presence in Europe, expanding in the U.S. (including Walmart, CVS, Ulta, Target and Amazon), entering India through Reliance Industries, and building a Dubai logistics hub for MENA distribution. The U.K. is a strategic focus through Primark and Boots placements.

Q: Will prices rise as Cosnova expands into skincare? A: Cosnova has committed to holding consumer prices steady in the U.S., reflecting a value positioning and the company’s family-owned emphasis on long-term brand equity. Skincare’s ingredient costs may increase COgs in some categories, but management has signaled a preference for stable consumer pricing.

Q: What are the main risks to this strategy? A: Integration risks (cultural fit and talent retention), regulatory and claims substantiation for skincare actives, supply chain complexity for specialized ingredients, potential channel conflict between DTC and retail, and margin pressure from higher ingredient costs are the primary concerns.

Q: Will Cosnova pursue more acquisitions? A: Leadership has communicated a cautious approach: while they would consider compelling opportunities, they do not expect to make another acquisition in the next two years as they focus on integrating Niche operationally and culturally.

Q: How will success be measured? A: Near-term metrics include retail distribution growth and DTC performance. Medium-term success will be an increased share of skincare revenue and stable margins. Long-term indicators include meaningful market share in accessible skincare and consistent international execution.

Q: What does this mean for consumers? A: Consumers should see more affordable, ingredient-backed skincare options backed by robust retail availability. The integration may drive wider distribution and more hybrid, skin-beneficial products that bridge make-up and skincare needs.

Q: How might competitors react? A: Competitors may accelerate their own investments in affordable active brands, pursue acquisitions, or expand private-label offerings. The market will evolve as larger companies adapt to the accessible, ingredient-first consumer segment.

Q: How will the new logistics investments help? A: A fully automated central warehouse slated for 2027 will increase operational capacity and speed. The regional logistics hub in Dubai will improve distribution efficiency across the Middle East and North Africa, reducing lead times and enhancing market responsiveness.

Q: How does Cosnova’s family ownership shape this strategy? A: Private, family ownership allows Cosnova to prioritize brand building and long-term equity over short-term margin maximization. That positioning underpins decisions like holding prices steady and taking a conservative M&A posture focused on successful integration.

Q: When should consumers expect Niche products in more stores? A: Niche had only recently begun offline distribution before the acquisition. With Cosnova’s retail infrastructure, expansion timelines will depend on category readiness, retailer assortment decisions and logistics ramp-up. Consumers can expect broader availability over the coming year as integration and distribution planning progress.

Q: How will Cosnova maintain authenticity for Niche? A: By preserving Niche’s team, headquarters and brand identity, Cosnova is signaling a commitment to authenticity. Maintaining transparency around formulations and continuing DTC engagement will be important to retain loyal customers.

Q: Can this model be replicated by other mass-market companies? A: Yes, the core playbook — acquire or incubate DTC brands with ingredient credibility, then scale via retail and logistics capabilities — is replicable. The challenge lies in preserving the acquired brand’s authenticity and ensuring regulatory and product quality standards are met at scale.

Q: What should investors and observers watch for in the next 12 months? A: Look for expansion into new retail doors, early sales performance of Niche products outside Spain, how Cosnova balances DTC vs. retail assortment, initial impacts on overall skincare revenue share, and evidence of successful cultural integration at the Canet de Mar hub.

Q: Will the acquisition change Cosnova’s product release cadence? A: Cosnova is likely to maintain its fast product cadence but tailored to the cycles and substantiation timelines of skincare. Expect a combination of hero product launches, accessible active offerings, and targeted limited editions designed to drive trial.

Q: How important is education in selling ingredient-led, value skincare? A: Education is critical. Consumers shop for actives because they want predictable outcomes. Clear packaging, plainspoken marketing, and educational content (e.g., usage instructions, expected timelines for benefits) will be essential to converting trial into repeat purchase.

Q: Could Cosnova’s approach push prices down in the accessible skincare segment? A: Increased competition and mass-market entrants can pressure price points. Cosnova’s commitment to steady pricing suggests a strategy to capture volume without aggressive discounting. However, retailers and competitors will influence market pricing dynamics.

Q: What broader industry trend does this acquisition reflect? A: The deal reflects consolidation and the mainstreaming of ingredient-led, affordable skincare: brands that started DTC and gained trust are becoming valuable assets for companies with distribution and operational scale.

Q: Where can consumers learn more about Niche Beauty Lab’s brands? A: Niche operates its brands DTC and has begun limited offline distribution. Specific availability will expand as Cosnova integrates operations and secures retail partnerships; official brand websites and major retailer sites will reflect new distribution as it rolls out.